Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective, J Natl Cancer Inst Monogr, pp.7-9, 1996. ,
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials, Ann Oncol, vol.28, pp.2077-85, 2017. ,
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer, Eur J Cancer Oxf Engl, vol.78, pp.133-141, 1990. ,
Building quality of life assessment into cancer treatment studies, Oncol Williston Park N, vol.6, pp.25-33, 1992. ,
Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients, Health Qual Life Outcomes, vol.3, p.55, 2005. ,
Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL), Qual Life Res, vol.2, pp.153-162, 1993. ,
Lessons learned from measuring health-related quality of life in oncology, J Clin Oncol Off J Am Soc Clin Oncol, vol.12, pp.608-624, 1994. ,
An attempt to include "quality of life" in evaluation of survival in bronchial cancer therapy, Bronches, vol.21, pp.215-224, 1971. ,
Quality and quantity of survival in acute myeloid leukaemia, Lancet Lond Engl, vol.2, pp.621-625, 1975. ,
Des recommandations de l'anesm sur la qualité de vie en ehpad : pourquoi ce thème ?, Empan, pp.126-158, 2013. ,
, Quality of Life Assessments in Clinical Trials, 1990.
Content validity of the quality of life index, Appl Nurs Res, vol.3, pp.126-133, 1990. ,
Quality of life in cancer: definition, purpose, and method of measurement, Cancer Invest, vol.11, pp.327-363, 1993. ,
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.9, pp.887-900, 2000. ,
Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research, Restor Neurol Neurosci, vol.20, pp.93-101, 2002. ,
Cancer risks in Swedish Lapps who breed reindeer, Am J Epidemiol, vol.132, pp.1078-82, 1990. ,
Who should measure quality of life?, BMJ, vol.322, pp.1417-1437, 2001. ,
Linking Clinical Variables With Health-Related Quality of Life: A Conceptual Model of Patient Outcomes, JAMA, vol.273, pp.59-65, 1995. ,
Endpoints in cancer clinical trials: is there a need for measuring quality of life? Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.3, pp.23-30, 1995. ,
Measuring quality of life: risks and benefits, Cancer Treat Rep, vol.69, pp.1115-1140, 1985. ,
Le concept de qualité de vie : les soins palliatifs et la qualité de vie, Rech Soins Infirm, pp.25-31, 2007. ,
Recommendations for evaluating the validity of quality of life claims for labeling and promotion, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.2, pp.113-140, 1999. ,
Assessing Quality of Life in Clinical Research: From Where Have We Come and Where Are We Going?, J Clin Epidemiol, vol.52, pp.355-63, 1999. ,
,
, Therapie, vol.44, pp.355-64, 1989.
Quality of life end points in cancer clinical trials: review and recommendations, vol.81, pp.485-95, 1989. ,
Health related quality of life and endpoints in oncology ,
, Cancer Radiother J Soc Francaise Radiother Oncol, vol.14, pp.515-523, 2010.
Endpoints in cancer clinical trials, J Visc Surg, vol.151, pp.17-22, 2014. ,
URL : https://hal.archives-ouvertes.fr/tel-01579503
Méthodes biostatistiques appliquées à la recherche clinique en cancérologie, 2018. ,
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data, Lancet Oncol, vol.14, pp.619-645, 2013. ,
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer, OncoTargets Ther, vol.11, pp.3059-63, 2018. ,
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials, Clin Breast Cancer, vol.18, pp.63-70, 2018. ,
Food and Drug Administration requirements for approval of new anticancer drugs, Cancer Treat Rep, vol.69, pp.1155-1164, 1985. ,
The experiences of cancer patients, QJM Mon J Assoc Physicians, vol.104, pp.1075-81, 2011. ,
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone, Ann Oncol Off J Eur Soc Med Oncol, vol.23, pp.1979-85, 2012. ,
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases, BMC Cancer, vol.12, p.283, 2012. ,
Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective, J Natl Cancer Inst Monogr, pp.7-9, 1996. ,
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, vol.30, pp.473-83, 1992. ,
SF-36 health survey: manual and interpretation guide. The Health Institute, 1993. ,
Quality of life in patients with traumatic brain injury-basic issues, assessment and recommendations, Restor Neurol Neurosci, vol.20, pp.111-135, 2002. ,
Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire, Anaesthesia, vol.52, pp.15-23, 1997. ,
Changes in quality of life after intensive care: comparison with normal data, Anaesthesia, vol.52, pp.195-202, 1997. ,
Health-related quality of life after acute lung injury, Am J Respir Crit Care Med, vol.156, pp.1120-1128, 1997. ,
Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome, Crit Care Med, vol.26, pp.651-660, 1998. ,
Quality of life after multiple trauma--summary and recommendations of the consensus conference, Restor Neurol Neurosci, vol.20, pp.161-168, 2002. ,
Development of the WHOQOL: Rationale and Current Status, Int J Ment Health, vol.23, pp.24-56, 1994. ,
, The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties, Soc Sci Med, vol.46, pp.1569-85, 1982.
Quality of life in the Danish general population--normative data and validity of WHOQOL-BREF using Rasch and item response theory models, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.13, pp.531-571, 2004. ,
, Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group, Psychol Med, vol.28, pp.551-559, 1998.
EuroQol--a new facility for the measurement of health-related quality of life, Health Policy Amst Neth, vol.16, pp.199-208, 1990. ,
Construction et validation des échelles de qualité de vie, Ann Réadapt Médecine Phys, vol.43, pp.263-272, 2000. ,
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, J Natl Cancer Inst, vol.85, pp.365-76, 1993. ,
, EORTC QLQ-C30 Scoring Manual
, European Organisation for Research and Treatment of Cancer, 2001.
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study, J Clin Oncol Off J Am Soc Clin Oncol, vol.14, pp.2756-68, 1996. ,
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.5, pp.139-50, 1996. ,
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure, J Clin Oncol Off J Am Soc Clin Oncol, vol.11, pp.570-579, 1993. ,
Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, Cent Outcomes Res Educ CORE, 1997. ,
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument, J Clin Oncol Off J Am Soc Clin Oncol, vol.15, pp.974-86, 1997. ,
Quality of Life: The Assessment, Analysis and Interpretation of Patientreported Outcomes ,
, , pp.2-2, 2018.
, , 1994.
Quality of Patient-Reported Outcome (PRO) Reporting Across Cancer Randomized Controlled Trials According to the CONSORT PRO Extension: A Pooled Analysis of 557 Trials, Cancer, vol.121, pp.3335-3377, 2015. ,
Inclusion of patientreported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov, 2007. ,
, Contemp Clin Trials, vol.43, pp.1-9, 2015.
Interpreting the significance of changes in health-related quality-of-life scores, J Clin Oncol, pp.139-183, 1998. ,
Measurement of health status: Ascertaining the minimal clinically important difference, Control Clin Trials, vol.10, pp.407-422, 1989. ,
Minimal clinically significant difference in health status: the thorny path of health status measures?, Eur Respir J, vol.19, pp.390-391, 2002. ,
Minimal clinically important differences: review of methods, J Rheumatol, vol.28, pp.406-418, 2001. ,
Defining clinically meaningful change in health-related quality of life, J Clin Epidemiol, vol.56, pp.395-407, 2003. ,
Interpretation of quality of life changes, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.2, pp.221-227, 1993. ,
Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales, J Pain Symptom Manage, vol.24, pp.547-61, 2002. ,
Understanding the minimum clinically important difference: a review of concepts and methods, Spine J Off J North Am Spine Soc, vol.7, pp.541-547, 2007. ,
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution-and anchor-based approaches, J Clin Epidemiol, vol.58, pp.1241-51, 2005. ,
Minimally important differences were estimated for six PROMIS-Cancer scales in advanced-stage cancer patients, J Clin Epidemiol, vol.64, pp.507-523, 2011. ,
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.19, pp.1753-60, 2011. ,
Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer, Asia Pac J Clin Oncol, vol.10, pp.109-126, 2014. ,
Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.23, pp.2731-2738, 2015. ,
,
Total knee replacement; minimal clinically important differences and responders, Osteoarthritis Cartilage, vol.21, pp.2006-2018, 2013. ,
, Mind the MIC: large variation among populations and methods -ScienceDirect, 2018.
Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain, Spine, vol.31, pp.578-82, 2006. ,
Examining the Minimal Important Difference of Patient-reported Outcome Measures for Individuals with Knee Osteoarthritis: A Model Using the Knee Injury and Osteoarthritis Outcome Score, J Rheumatol, vol.43, pp.395-404, 2016. ,
Three ways to quantify uncertainty in individually applied "minimally important change" values, J Clin Epidemiol, vol.63, pp.37-45, 2010. ,
Applied logistic regression, 2000. ,
Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis, J Clin Epidemiol, vol.68, pp.1388-96, 2015. ,
Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach, J Clin Epidemiol, vol.50, pp.869-79, 1997. ,
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing reirradiation for painful bone metastases, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.27, pp.1089-98, 2018. ,
Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients, Asia Pac J Clin Oncol, vol.12, pp.38-46, 2016. ,
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.25, pp.2535-2576, 2016. ,
The minimal clinical important difference in the World Health Organization Quality of Life instrument--100, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.21, pp.1295-301, 2013. ,
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.5, pp.555-67, 1996. ,
Interpreting differences in quality of life: the FACT-H&N in laryngeal cancer patients, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.13, pp.725-758, 2004. ,
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592, J Clin Epidemiol, vol.55, pp.285-95, 2002. ,
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.19, pp.1753-60, 2011. ,
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer, Health Qual Life Outcomes, vol.5, p.70, 2007. ,
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients, Ann Oncol, vol.22, pp.2107-2119, 2011. ,
Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma, Ann Oncol Off J Eur Soc Med Oncol, vol.17, pp.304-316, 2006. ,
Establishing anchorbased minimally important differences (MID) with the EORTC quality-of-life measures: a metaanalysis protocol, BMJ Open, 2018. ,
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, vol.61, pp.102-111, 2008. ,
Interpretation of quality of life changes, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.2, pp.221-227, 1993. ,
Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation, Med Care, vol.41, pp.582-92, 2003. ,
Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.11, pp.207-228, 2002. ,
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II, PharmacoEconomics, vol.15, pp.141-55, 1999. ,
A combination of distribution-and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale, J Clin Epidemiol, vol.57, pp.898-910, 2004. ,
Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, vol.52, pp.861-73, 1999. ,
Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults, Med Care, vol.36, pp.1589-98, 1998. ,
Individual-patient monitoring in clinical practice: are available health status surveys adequate?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.4, pp.293-307, 1995. ,
Distribution-based and anchor-based approaches provided different interpretability estimates for the Hydrocephalus Outcome Questionnaire, J Clin Epidemiol, vol.59, pp.176-84, 2006. ,
Responsiveness of common outcome measures for patients with low back pain, Spine, vol.24, pp.1805-1817, 1999. ,
The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?, PharmacoEconomics, vol.18, pp.419-442, 2000. ,
Statistical Power Analysis for the Behavioral Sciences -1st Edition ,
Sensitivity and specificity of outcome measures in patients with neck pain: detecting clinically significant improvement, Spine, vol.29, pp.2410-2417, 2004. ,
Clinical significance: a statistical approach to defining meaningful change in psychotherapy research, J Consult Clin Psychol, vol.59, pp.12-21, 1991. ,
Comparisons of five health status instruments for orthopedic evaluation, Med Care, vol.28, pp.632-674, 1990. ,
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders, J Clin Epidemiol, vol.50, pp.79-93, 1997. ,
SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions, Qual Health Care QHC, vol.3, pp.186-92, 1994. ,
Minimal clinically important differences: review of methods, J Rheumatol, vol.28, pp.406-418, 2001. ,
Consensus development methods: a review of best practice in creating clinical guidelines, J Health Serv Res Policy, vol.4, pp.236-284, 1999. ,
The Delphi technique: a worthwhile research approach for nursing?, J Adv Nurs, vol.19, pp.1221-1226, 1994. ,
Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis, J Rheumatol, vol.34, pp.280-289, 2007. ,
Assessing the minimal important difference in symptoms: a comparison of two techniques, J Clin Epidemiol, vol.49, pp.1215-1224, 1996. ,
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review, BMC Cancer, vol.16, p.122, 2016. ,
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma, Eur J Cancer, vol.46, pp.2753-62, 2010. ,
Applying Survival Data Methodology to Analyze Longitudinal Quality of Life Data, Stat Methods Qual Life Stud Des Meas Anal ,
, , pp.231-274, 2002.
Time to health-related quality of life score deterioration as a modality of longitudinal analysis for healthrelated quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.24, pp.5-18, 2015. ,
Time to Deterioration in Quality of Life Score as a Modality of Longitudinal Analysis in Patients with Breast Cancer, The Oncologist, vol.16, pp.1458-68, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00687536
Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumabrefractory HER2+ metastatic breast cancer, Ann Oncol Off J Eur Soc Med Oncol, vol.22, pp.2582-90, 2011. ,
Design and Analysis of Quality of Life Studies in Clinical Trials, Interdisciplinary Statistics Series, 2002. ,
Applications of health-related quality of life for guiding health care: advances in response shift research, J Clin Epidemiol, vol.62, pp.1115-1122, 2009. ,
Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal, Health Qual Life Outcomes, vol.2, p.16, 2004. ,
The clinical significance of adaptation to changing health: a meta-analysis of response shift, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.15, pp.1533-50, 2006. ,
Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift, Health Qual Life Outcomes, vol.2, p.14, 2004. ,
Response-shift bias: A source of contamination of self-report measures, J Appl Psychol, vol.64, pp.144-50, 1979. ,
Underreporting by cancer patients: the case of response-shift, Soc Sci Med, vol.32, pp.981-988, 1982. ,
Integrating response shift into health-related quality of life research: a theoretical model, Soc Sci Med, vol.48, pp.1507-1522, 1999. ,
Response shift: a brief overview and proposed research priorities, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.18, pp.335-381, 2009. ,
Internal invalidity in pretest-posttest self-report evaluations and a re-evaluation of retrospective pretests, Appl Psychol Meas, vol.3, pp.1-23, 1979. ,
Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials, Cancer Treat Rev, vol.22, pp.55-62, 1996. ,
Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients, Health Qual Life Outcomes, vol.8, p.65, 2010. ,
Tests of measurement invariance failed to support the application of the "then-test, J Clin Epidemiol, vol.62, pp.1173-80, 2009. ,
Guidelines for improving the stringency of response shift research using the thentest, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.19, pp.455-64, 2010. ,
Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research, Soc Sci Med, vol.48, pp.1531-1579, 1999. ,
Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study, Qual Life Res, vol.22, pp.1-11, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00687542
A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS, BMJ, vol.313, pp.29-33, 1996. ,
Individual quality of life in patients undergoing hip replacement, Lancet Lond Engl, vol.339, pp.1088-91, 1992. ,
Techniques of attitude scale construction, 1957. ,
Preference value assessment: card sort approach, Front Sci Technol Found, 1996. ,
Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study, Soc Sci Med, vol.63, pp.911-920, 1982. ,
Change in quality of life of people with stroke over time: true change or response shift?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.14, pp.611-638, 2005. ,
The Use Of Analysis Of Covariance Structures To Assess Beta And Gamma Change, Multivar Behav Res, vol.17, pp.343-58, 1982. ,
Comparison of Three Techniques to Assess Group-Level Beta and Gamma Change , Comparison of Three Techniques to Assess Group-Level Beta and Gamma Change, Appl Psychol Meas, vol.8, pp.249-60, 1984. ,
Confirmatory Factor Analytic Procedures for Assessing Change During Organizational Entry, J Appl Psychol, vol.74, pp.892-900, 1989. ,
Assessment of response shift using two structural equation modeling techniques, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.22, pp.461-71, 2013. ,
Using structural equation modeling to detect response shifts and true change, Qual Life Res, vol.14, pp.587-98, 2005. ,
The Oort structural equation modeling approach detected a response shift after a COPD self-management program not detected by the Schmitt technique, J Clin Epidemiol, vol.62, pp.1165-72, 2009. ,
Relative importance measures for reprioritization response shift, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.22, pp.695-703, 2013. ,
Changing values, changing outcomes: the influence of reprioritization response shift on outcome assessment after spine surgery, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.22, pp.2255-64, 2013. ,
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients, Health Qual Life Outcomes, vol.12, p.32, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00997569
, Rasch Models: Foundations, Recent Developments, and Applications, 1995.
RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in longitudinal patient-reported outcome studies, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.24, pp.553-64, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01815975
Impact of response shift on longitudinal quality-oflife assessment in cancer clinical trials, Expert Rev Pharmacoecon Outcomes Res, vol.11, pp.549-59, 2011. ,
Minimal important differences and response shift in healthrelated quality of life; a longitudinal study in patients with multiple myeloma, Health Qual Life Outcomes, vol.8, p.79, 2010. ,
Impact of response shift on longitudinal quality-oflife assessment in cancer clinical trials, Expert Rev Pharmacoecon Outcomes Res, vol.11, pp.549-59, 2011. ,
Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis, Arthritis Rheum, vol.43, pp.1478-87, 2000. ,
An integrated method to determine meaningful changes in health-related quality of life, J Clin Epidemiol, vol.57, pp.1153-60, 2004. ,
The minimal clinically important difference determined using item response theory models: an attempt to solve the issue of the association with baseline score, J Clin Epidemiol, vol.67, pp.433-473, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00936664
Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.13, pp.1409-1423, 2004. ,
Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life, Med Care, vol.37, pp.469-78, 1999. ,
Smallest real difference, a link between reproducibility and responsiveness, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.10, pp.571-579, 2001. ,
Using structural equation modeling to detect response shifts and true change in discrete variables: an application to the items of the SF-36, Qual Life Res, vol.25, pp.1361-83, 2016. ,
An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery, Qual Life Res, vol.14, pp.599-609 ,
, Modèles à équations structurelles pour caractériser l'occurrence de la « Response-Shift » dans l'évaluation longitudinale de la qualité de vie relative à la santé | Request PDF
, , 2018.